Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test
Go back to Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.22 +0.03 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.19 | 52 Week High | $45.34 | |||
| Open | $3.17 | 52 Week Low | $15.92 | |||
| Day High | $3.30 | P/E | 1.38 | |||
| Day Low | $3.14 | EPS | $2.33 | |||
| Volume | 983,004 | |||||
| (NASDAQ: SOPH) | Delayed: 8.39 +0.11 (1.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.28 | 52 Week High | $ | |||
| Open | $8.41 | 52 Week Low | $ | |||
| Day High | $8.44 | P/E | N/A | |||
| Day Low | $8.10 | EPS | $ | |||
| Volume | 509,788 | |||||
